GENETIC TESTING OPTIONS Testing options include full gene sequencing of BRCA1 and BRCA2 exons by NGS targeted sequencing, analysis of common and/or rare deletions and duplications in BRCA1 and BRCA2. ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, FANCC, MLH1, MSH2, MSH6, NBN, NF1, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53 This panel includes 20 high and moderate risk genes for breast and ovarian cancer. It is appropriate for individuals with family or personal history of multiple cancers suggestive of a hereditary cancer syndrome, It is appropriate for individuals with family or personal history of multiple cancers, including breast and ovarian cancer, suggestive of a hereditary cancer syndrome. 11 Genes Breast Cancer Risk Assessment and Management Panel 20 Genes Hereditary Breast & Ovarian Cancer Panel 2 Genes BRCA1 & BRCA2 Analysis Henry Ford Center for Precision Diagnostics BRCA1, BRCA2, CHEK2, ATM, PALB2, TP53, CDH1, PTEN, NF1, NBN, STK11 This panel includes 11 genes with established risk estimates for breast cancer and other related cancers. See NCCN guidelines for cancer screening and medical management options.